Statement Of Cash Flows [Abstract]

Captor Therapeutics S.A. - Filing #6216905

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2021-01-01
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-01-01
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
32 572 PLN
32 572 PLN
32 572 PLN
12 694 PLN
12 694 PLN
12 694 PLN
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in other operating receivables
68,000 PLN
2 539 PLN
Adjustments for depreciation and amortisation expense
7 355 PLN
6 602 PLN
Adjustments for provisions
5 536 PLN
503,000 PLN
Adjustments for unrealised foreign exchange losses (gains)
36,000 PLN
12,000 PLN
Adjustments for share-based payments
9 495 PLN
1 734 PLN
Adjustments to reconcile profit (loss)
4 099 PLN
12 099 PLN
Cash flows from (used in) operating activities
28 473 PLN
595,000 PLN
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
5 113 PLN
212,000 PLN
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
148 240 PLN
5 600 PLN
Repayments of borrowings, classified as financing activities
209,000 PLN
Payments of lease liabilities, classified as financing activities
6 747 PLN
6 103 PLN
Interest paid, classified as financing activities
409,000 PLN
378,000 PLN
Cash flows from (used in) financing activities
140 875 PLN
881,000 PLN
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
107 289 PLN
1 688 PLN
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
107 289 PLN
1 688 PLN
Cash and cash equivalents
117 943 PLN
10 654 PLN
10 654 PLN
12 342 PLN

Talk to a Data Expert

Have a question? We'll get back to you promptly.